Jacelyn Ann Harrington, | |
100 Locust Valley Rd, Exeter, RI 02822-3212 | |
(401) 536-5613 | |
Not Available |
Full Name | Jacelyn Ann Harrington |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 100 Locust Valley Rd, Exeter, Rhode Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508574393 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Jacelyn Ann Harrington, 100 Locust Valley Rd, Exeter, RI 02822-3212 Ph: (401) 536-5613 | Jacelyn Ann Harrington, 100 Locust Valley Rd, Exeter, RI 02822-3212 Ph: (401) 536-5613 |
News Archive
Bioengineers at Yale and Cornell have created a modified chemotherapy that more effectively reaches and remains at the site of brain tumors — by adding a water-soluble polymer to the anti-cancer drug, according to a report in the November-December issue of Bioconjugate Chemistry.
The Bluetooth SIG has awarded Edward Sazonov, Physical Activity Innovations LLC, the title of Bluetooth Innovator of the Year for 2009. Sazonov received this recognition at the official award ceremony held in-line with the Wearable Technologies Show at ispo 2010, the world's largest trade show for sporting goods.
Inflammatory cytokines are molecules that are secreted by immune cells to promote inflammation. A study published in the Journal of Orthopaedic Research found that measuring inflammatory cytokines may help predict patient outcomes after traumatic injury, which is the leading cause of mortality in individuals under 50 years of age.
Researchers at Okayama University report in the Journal of Artificial Organs the promising performance of a retinal prosthesis material when implanted in rats. The material is capable of converting external light stimuli into electric potentials that are picked up by neurons.
The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin a diabetes research collaboration with Pfizer, Hadassah Medical Organization, and The Hebrew University of Jerusalem on drugs to replicate and regenerate insulin-producing cells in people with type 1 diabetes.
› Verified 8 days ago